Accuray Inc (ARAY)

5.38
0.02 0.37
NASDAQ : Health Care
Prev Close 5.36
Open 5.37
Day Low/High 5.35 / 5.43
52 Wk Low/High 4.75 / 7.54
Volume 258.71K
Avg Volume 680.10K
Exchange NASDAQ
Shares Outstanding 80.92M
Market Cap 431.33M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Accuray Receives 510(k) FDA Clearance For The Radixact™ Image-Guided Radiation Therapy Platform And Integrated Software

Accuray Receives 510(k) FDA Clearance For The Radixact™ Image-Guided Radiation Therapy Platform And Integrated Software

Next Generation "Smart" System Enables Clinicians to Provide Highly Precise Treatment, Efficiently, for More Patients, Every Day

FUCAM Treats 1,000 Breast Cancer Patients With The TomoTherapy® System

FUCAM Treats 1,000 Breast Cancer Patients With The TomoTherapy® System

System Dedicated Solely to Breast Cancer Care Provides Excellent Clinical Outcomes

United Kingdom's NHS Supply Chain To Acquire Seven TomoTherapy® Systems

United Kingdom's NHS Supply Chain To Acquire Seven TomoTherapy® Systems

Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments

Commit To Purchase Accuray At $5, Earn 23.2% Annualized Using Options

Commit To Purchase Accuray At $5, Earn 23.2% Annualized Using Options

Investors considering a purchase of Accuray Inc shares, but tentative about paying the going market price of $5.30/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $5 strike, which has a bid at the time of this writing of 40 cents.

Accuray Signs Long-Term Strategic Development And Supply Agreement With MedPhoton For Volumetric Image Guidance Solutions For The CyberKnife® System

Accuray Signs Long-Term Strategic Development And Supply Agreement With MedPhoton For Volumetric Image Guidance Solutions For The CyberKnife® System

Collaboration Designed to Expand Clinical Versatility of the CyberKnife® System with Addition of medPhoton Novel Imaging Solution

Accuray Hosts Regional AERO Users' Meeting

Accuray Hosts Regional AERO Users' Meeting

Leading Oncology Specialists Discuss Best Practices and Innovations in Cancer Treatment

Accuray (ARAY) Strong On High Relative Volume Today

Accuray (ARAY) Strong On High Relative Volume Today

Trade-Ideas LLC identified Accuray (ARAY) as a strong on high relative volume candidate

MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients With The CyberKnife® System

MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients With The CyberKnife® System

Patients Benefit from Fewer Treatment Sessions and Minimal Side Effects

Commit To Purchase Accuray At $4, Earn 17.7% Annualized Using Options

Commit To Purchase Accuray At $4, Earn 17.7% Annualized Using Options

Investors eyeing a purchase of Accuray Inc stock, but tentative about paying the going market price of $5.03/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $4 strike, which has a bid at the time of this writing of 25 cents.

Accuray Announces First Radiation Therapy Systems Installed In Qatar, Latvia And Bulgaria

Accuray Announces First Radiation Therapy Systems Installed In Qatar, Latvia And Bulgaria

Premier Qatar, Latvian Cancer Centers to Offer Patients Treatment with the CyberKnife® System; Leading Bulgarian Hospital to Provide Treatment with the TomoTherapy® System

RSI Alert: Accuray (ARAY) Now Oversold

RSI Alert: Accuray (ARAY) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Accuray Breaks Above 200-Day Moving Average - Bullish for ARAY

Accuray Breaks Above 200-Day Moving Average - Bullish for ARAY

In trading on Thursday, shares of Accuray Inc crossed above their 200 day moving average of $6.96, changing hands as high as $7.13 per share. Accuray Inc shares are currently trading up about 3.2% on the day.

Accuray Hosts First Regional Users' Meeting

Accuray Hosts First Regional Users' Meeting

Clinicians Gather to Foster Industry Collaboration and Discuss Best Practices in Radiation Therapy

Accuray (ARAY) Highlighted As Weak On High Volume

Accuray (ARAY) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Accuray (ARAY) as a weak on high relative volume candidate

Accuray (ARAY) Flagged As Strong On High Volume

Accuray (ARAY) Flagged As Strong On High Volume

Trade-Ideas LLC identified Accuray (ARAY) as a strong on high relative volume candidate

New CyberKnife® And TomoTherapy® System Data Presented At Leading Scientific Industry Meeting

New CyberKnife® And TomoTherapy® System Data Presented At Leading Scientific Industry Meeting

Excellent Treatment Outcomes for a Wide Range of Tumor Types Demonstrated by Accuray CyberKnife and TomoTherapy Systems

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Accuray Incorporated

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Breaches Of Fiduciary Duty By The Board Of Accuray Incorporated

Levi & Korsinsky announces it has commenced an investigation of Accuray Incorporated (NASDAQGS:ARAY) concerning possible breaches of fiduciary duty by the board of directors of the company.

First Week of ARAY June 2016 Options Trading

First Week of ARAY June 2016 Options Trading

Investors in Accuray Inc saw new options become available this week, for the June 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

'Mad Money' Lightning Round: Buy, Buy, Buy Kohlberg Kravis Roberts

'Mad Money' Lightning Round: Buy, Buy, Buy Kohlberg Kravis Roberts

Cramer prefers HollyFrontier to CVR Refining and Nordic American Tanker over GasLog.